DBV Technologies S.A.
DBVT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001613780
No open-market purchases or sales by DBV Technologies S.A. insiders were filed in the last 90 days; 80 institutions reported holding it in 13F filings for Q2 2026, worth $345.9M in total; Duquesne Family Office is the only superinvestor holding it.
Other share classesDBVTF
Politicians who traded DBVT
No member of Congress has reported a trade in DBV Technologies S.A. shares or options since 2020.
Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report. Profiles, committees and photos: the unitedstates project (public domain). District maps: U.S. Census Bureau.